Polydex Pharmaceuticals Limited (OTCMKTS:POLXF – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.99 and traded as low as $1.99. Polydex Pharmaceuticals shares last traded at $1.99, with a volume of 2,000 shares changing hands.
Polydex Pharmaceuticals Price Performance
The stock has a market cap of $6.81 million and a P/E ratio of -8.27. The stock’s 50 day simple moving average is $1.99 and its two-hundred day simple moving average is $1.99.
Polydex Pharmaceuticals Company Profile
Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market.
See Also
- Five stocks we like better than Polydex Pharmaceuticals
- What Are Dividend Contenders? Investing in Dividend Contenders
- Silicon Motion Proves That AI in Motion Stays in Motion
- What is Short Interest? How to Use It
- Undervalued UnitedHealth Group Won’t Be For Long
- Insider Trading – What You Need to Know
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
